Renowned faculty discuss the diagnosis of prediabetes and diabetes, including atypical forms of diabetes in adults. This course reviews the role of lifestyle interventions as well as appropriate indications and practical use of weight loss medications. The growing role of diabetes technology will be addressed as well as the risks and benefits of new insulin and noninsulin pharmacologic therapies, diabetes medications, cholesterol-lowering agents, and blood pressure control to reduce cardiometabolic risk .
This extensive collection of virtual lectures will cover:
- Current guidelines for the management of patients with diabetes and prediabetes.
- Guidance on the evaluation, classification, and treatment of diabetes, including less common atypical forms of diabetes.
- New insulin products and diabetes technology (including new pens, pumps, and sensors) available for patients with type 1 and 2 diabetes.
- The rapidly expanding role of noninsulin therapeutics in the management of type 2 diabetes.
- The role of nutrition and medication use for weight management in patients with obesity and diabetes.
- Prevention and treatment of cardiovascular disease in patients with diabetes.
- Appropriate evaluation and evidence-based treatments for metabolic dysfunction-associated steatotic liver disease (MASLD).
Course Director:
Irl B. Hirsch, MD, MACP
Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, WA
Copyright 2026 American College of Physicians. All Rights Reserved.
CME/MOC:
Up to 6.75
AMA PRA Category 1 Credits™ and MOC Points
Expires July 26, 2029
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Internal Medicine Meeting Recordings
ACP's Internal Medicine Meeting Recording packages include video and slide presentations from a curated selection of popular and highly rated sessions delivered during or derived from the ACP Internal Medicine Meeting. Trusted, timely content in general internal medicine and the subspecialties is presented by expert faculty; CME and MOC available.
Disclosures
Grazia Aleppo, MD, FACP
Grant/Contract: Welldoc, Insulet Corporation, Bayer Healthcare, Fractyl, Mannkind; Consultant: Dexcom, Medscape, Tandem Diabetes Care
Irl Hirsch, MD, MACP
Consultant: Roche Diabetes Care, Abbott Diabetes Care, Gwave, Sequel
Janet McGill, MD, FACP
Consultant: Abbott Labs, Bayer Healthcare, Novo Nordisk, Lexicon Pharmaceuticals, Vertex Pharma, Eli Lilly, Mannkind Corp
Savitha Subramarian, MD
Consultant: Abbott Diabetes Care, Arrowhead Pharmaceuticals, New Amsterdam Pharmaceuticals, Ionis Pharmaceuticals
Arthi Thirumalai, MBBS
Grant/Contract: Novo Nordisk, Fractyl Health; Consultant: Novo Nordisk
All of the above relationships in italics have been mitigated. None of the remaining planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
CME Accreditation and MOC Information
The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Physicians designate this enduring material, Diabetes for Internal Medicine Physicians, for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 6.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.